Dibotermin alfa
Inductos (dibotermin alfa) is a protein pharmaceutical. Dibotermin alfa was first approved as Inductos on 2002-09-09. It has been approved in Europe to treat internal fracture fixation, spinal fusion, and tibial fractures.
| Trade Name | Inductos |
|---|---|
| Common Name | Dibotermin alfa |
| Indication | internal fracture fixation, spinal fusion, tibial fractures |
| Drug Class | Growth factors: bone morphogenetic proteins|growth factors: transforming growth factors |
